Table 2.
Age-adjusted prevalence of Pgp3, % (95% CI) | Age-adjusted prevalence of Ct694, % (95% CI) | |||
---|---|---|---|---|
EU | 1–9 y | ≥15 y | 1–9 y | ≥15 y |
Boudoukou 1 | 5.3 (1.5 to 15.6) |
57.0 (39.1 to 74.0) |
5.2 (1.2 to 15.6) |
33.8 (19.4 to 53.4) |
Bangolo 2 | 8.2 (4.7 to 13.7) |
73.6 (61.0 to 83.8) |
8.7 (5.1 to 14.3) |
56.8 (44.4 to 69.0) |